0000950170-25-019904.txt : 20250213
0000950170-25-019904.hdr.sgml : 20250213
20250213161506
ACCESSION NUMBER: 0000950170-25-019904
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250213
DATE AS OF CHANGE: 20250213
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Rapport Therapeutics, Inc.
CENTRAL INDEX KEY: 0002012593
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 880724208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-94532
FILM NUMBER: 25620451
BUSINESS ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: 857-321-8020
MAIL ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02215
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Third Rock Ventures V, L.P.
CENTRAL INDEX KEY: 0001778071
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0001778071
XXXXXXXX
LIVE
Common Stock, $0.001 par value per share
12/31/2024
0002012593
Rapport Therapeutics, Inc.
75383L102
1325 Boylston Street
Suite 401
Boston
MA
02215
Rule 13d-1(d)
Third Rock Ventures V, L.P.
b
DE
0
7135233
0
7135233
7135233
N
19.5
PN
Third Rock Ventures GP V, L.P.
b
DE
0
7135233
0
7135233
7135233
N
19.5
PN
TRV GP V, LLC
b
DE
0
7135233
0
7135233
7135233
N
19.5
OO
Third Rock Ventures VI, L.P.
b
DE
0
969218
0
969218
969218
N
2.7
PN
Third Rock Ventures GP VI, L.P.
b
DE
0
969218
0
969218
969218
N
2.7
PN
TRV GP VI, LLC
b
DE
0
969218
0
969218
969218
N
2.7
OO
Rapport Therapeutics, Inc.
1325 Boylston Street, Suite 401, Boston, MA 02215
(i) Third Rock Ventures V, L.P. ("TRV V");
(ii) Third Rock Ventures GP V, L.P. ("TRV GP V"), which is the sole general partner of TRV V;
(iii) TRV GP V, LLC ("TRV GP V LLC"), which is the sole general partner of TRV GP V;
(iv) Third Rock Ventures VI, L.P. ("TRV VI");
(v) Third Rock Ventures GP VI, L.P. ("TRV GP VI"), which is the sole general partner of TRV VI; and
(vi) TRV GP VI, LLC ("TRV GP VI LLC"), which is the sole general partner of TRV GP VI.
The address of the principal business office of each of the Reporting Persons is Third Rock Ventures, LLC, 201 Brookline Ave, Suite 1401, Boston, MA 02215.
Each of TRV V, TRV GP V, TRV VI and TRV GP VI is a Delaware limited partnership. Each of TRV GP V LLC and TRV GP VI LLC is a Delaware limited liability company.
Y
(i) TRV V directly owns 7,135,233 shares of Common Stock (the "V Shares")
(ii) TRV GP V is the general partner of TRV V and may be deemed to beneficially own the V Shares.
(iii) TRV GP V LLC is the general partner of TRV GP V and may be deemed to beneficially own the V Shares.
(iv) TRV VI directly owns 969,218 shares of Common Stock (the "VI Shares").
(v) TRV GP VI is the general partner of TRV VI and may be deemed to beneficially own the VI Shares.
(vi) TRV GP VI LLC is the general partner of TRV GP VI and may be deemed to beneficially own the VI Shares.
Each of TRV V, TRV GP V, and TRV GP V LLC, on the one hand, and TRV VI, TRV GP VI and TRV GP VI LLC, on the other hand, disclaim the existence of a "group" for purposes of Rule 13d-5 of the Securities Exchange Act of 1934, as amended, and nothing contained in this report shall be deemed an admission that any such group exists or may exist.
The V shares represent approximately 19.5% of the outstanding shares of Common Stock.
The VI shares represent approximately 2.7% of the outstanding shares of Common Stock.
The percent of class was calculated based on 36,576,457 shares of common stock issued and outstanding as of November 6, 2024, as disclosed in the Issuer's 10-Q filed with the Securities and Exchange Commission on November 7, 2024.
TRV V - 0
TRV GP V - 0
TRV GP V LLC - 0
TRV VI - 0
TRV GP VI - 0
TRV GP VI LLC - 0
TRV V - 7,135,233 shares
TRV GP V - 7,135,233 shares
TRV GP V LLC - 7,135,233 shares
TRV VI - 969,218 shares
TRV GP VI - 969,218 shares
TRV GP VI LLC - 969,218 shares
TRV V - 0
TRV GP V - 0
TRV GP V LLC - 0
TRV VI - 0
TRV GP VI - 0
TRV GP VI LLC - 0
TRV V - 7,135,233 shares
TRV GP V - 7,135,233 shares
TRV GP V LLC - 7,135,233 shares
TRV VI - 969,218 shares
TRV GP VI - 969,218 shares
TRV GP VI LLC - 969,218 shares
Y
Y
Y
Y
Y
Y
Third Rock Ventures V, L.P.
/s/ Kevin Gillis
Kevin Gillis, COO of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P.
02/13/2025
Third Rock Ventures GP V, L.P.
/s/ Kevin Gillis
Kevin Gillis, Chief Operating Officer of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P
02/13/2025
TRV GP V, LLC
/s/ Kevin Gillis
Kevin Gillis, Chief Operating Officer of TRV GP V, LLC
02/13/2025
Third Rock Ventures VI, L.P.
/s/ Kevin Gillis
Kevin Gillis, COO of TRV GP VI, LLC, general partner of Third Rock Ventures GP VI, L.P., general partner of Third Rock Ventures VI, L.P.
02/13/2025
Third Rock Ventures GP VI, L.P.
/s/ Kevin Gillis
Kevin Gillis, Chief Operating Officer of TRV GP VI, LLC, general partner of Third Rock Ventures GP VI, L.P.
02/13/2025
TRV GP VI, LLC
/s/ Kevin Gillis
Kevin Gillis, Chief Operating Officer of TRV GP VI, LLC
02/13/2025